Dyne Therapeutics (DYN) EBIT (2019 - 2026)
Dyne Therapeutics' (DYN) quarterly EBIT came in at -$125.3 million in Q1 2026, down 2.37% year-on-year from -$128.3 million in Q1 2025, and down 7.88% on a QoQ basis from -$116.1 million in Q4 2025.
Dyne Therapeutics (DYN) EBIT (2019 - 2026) Analysis & Trends
Dyne Therapeutics (DYN) has 8 years of EBIT data on file, last reported at -$125.3 million in Q1 2026.
- On a quarterly basis, EBIT fell 2.37% year-over-year to -$125.3 million in Q1 2026; TTM through Mar 2026 was -$471.1 million, a 18.66% decrease from a year earlier, with the FY2025 full-year figure at -$468.2 million, down 36.15% from the prior year.
- EBIT for Q1 2026 stood at -$125.3 million, down from -$116.1 million in the prior quarter.
- Over the last five years, EBIT for DYN reached as high as -$35.8 million in Q1 2022 and fell as low as -$125.3 million in Q1 2026.
- Historically, EBIT has averaged -$79.4 million across 5 years, with a median of -$69.2 million in 2024.
- Across the five-year window, EBIT gained 22.74% in 2022 and tumbled 76.95% in 2025, its largest moves.
- Year by year, EBIT stood at -$40.1 million in 2022, then plunged by 68.61% to -$67.7 million in 2023, then slumped by 43.46% to -$97.1 million in 2024, then dropped by 19.59% to -$116.1 million in 2025, then declined by 7.88% to -$125.3 million in 2026.
- Per Business Quant data, the three most recent EBIT figures were -$125.3 million in Q1 2026, -$116.1 million in Q4 2025, and -$113.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Dyne Therapeutics | 3.94 Bn | 3.94 Bn | - | -125.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -125.28 Mn |
| Dec 31, 2025 | -116.13 Mn |
| Sep 30, 2025 | -113.89 Mn |
| Jun 30, 2025 | -115.79 Mn |
| Mar 31, 2025 | -122.37 Mn |
| Dec 31, 2024 | -97.11 Mn |
| Sep 30, 2024 | -105.57 Mn |
| Jun 30, 2024 | -71.96 Mn |
| Mar 31, 2024 | -69.16 Mn |
| Dec 31, 2023 | -67.69 Mn |
| Sep 30, 2023 | -62.27 Mn |
| Jun 30, 2023 | -66.74 Mn |
| Mar 31, 2023 | -45.46 Mn |
| Dec 31, 2022 | -40.15 Mn |
| Sep 30, 2022 | -42.28 Mn |
| Jun 30, 2022 | -52.76 Mn |
| Mar 31, 2022 | -35.78 Mn |
| Dec 31, 2021 | -51.96 Mn |
| Sep 30, 2021 | -42.77 Mn |
| Jun 30, 2021 | -30.17 Mn |